id_in_original_dataset,text,labels,gemini_pro_one_shot,gemini_pro_one_shot_time,gemini_pro_five_shot,gemini_pro_five_shot_time,gemini_pro_ten_shot,gemini_pro_ten_shot_time,gemini_pro_twenty_shot,gemini_pro_twenty_shot_time,gemini_pro_one_shot_labels,gemini_pro_five_shot_labels,gemini_pro_ten_shot_labels,gemini_pro_twenty_shot_labels
63955,[E2] metronidazole [E2/] [E1] 500/mg [E1/] Tablet Sig : One/(/1/) Tablet PO Q8H ( every 8 hours ) : TO END [ ** 2137-11-9 ** ] .,1,DOSAGE-DRUG,0.6603038311004639,DOSAGE-DRUG,0.519740104675293,DOSAGE-DRUG,0.5222539901733398,FREQUENCY-DRUG,0.5942647457122803,5,5,5,3
59566,"Gen : Lying in bed , NAD .",0,No relation,0.5095651149749756,No relation,0.7148721218109131,No relation,0.3982560634613037,No relation,0.5449099540710449,0,0,0,0
27673,[E2] Caspofungin [E2/] 50/mg Recon/Soln Sig : One/(/1/) Recon/Soln [E1] Intravenous [E1/] Q24H/(/every/24/hours/) .,2,DOSAGE-DRUG,0.36812591552734375,DOSAGE-DRUG,0.5078220367431641,DOSAGE-DRUG,0.5368988513946533,FREQUENCY-DRUG,0.5246777534484863,5,5,5,3
25714,[E2] Oxycodone/- [E2/] Acetaminophen 5/-/325/mg Tablet Sig : 1/-/2 Tablets PO [E1] Q4H/(/every/4/hours/)/as/needed [E1/] for pain .,3,DOSAGE-DRUG,0.3215758800506592,DOSAGE-DRUG,0.4023423194885254,DOSAGE-DRUG,0.4711880683898926,FREQUENCY-DRUG,0.4898660182952881,5,5,5,3
45556,[E2] Camphor/-/Menthol [E2/] [E1] 0.5/-/0.5 [E1/] % Lotion Sig : One/(/1/) Appl Topical QID/(/4/times/a/day/)/as/needed for pruritis .,1,FORM-DRUG,0.434251070022583,DOSAGE-DRUG,0.4871337413787842,DOSAGE-DRUG,0.5237257480621338,DOSAGE-DRUG,0.523486852645874,4,5,5,5
42475,[E2] Acetaminophen [E2/] 325/mg Tablet Sig : [E1] 1/-/2 [E1/] Tablets PO Q6H/(/every/6 hours ) as needed for fever or pain : Not to exceed 4gm per day .,5,DOSAGE-DRUG,0.516599178314209,DOSAGE-DRUG,0.5214879512786865,DOSAGE-DRUG,0.5218610763549805,DOSAGE-DRUG,0.5421431064605713,5,5,5,5
52633,"Her urine culture eventually speciated as pansensitive staphylococcus aureus , and she was transitioned to oral [E2] augmentin [E2/] to compelte a total [E1] 14/day [E1/] course following discharge .",7,DOSAGE-DRUG,0.49957895278930664,DURATION-DRUG,0.34606504440307617,DURATION-DRUG,0.37429237365722656,DURATION-DRUG,0.5173592567443848,5,7,7,7
81233,5 .,0,DURATION-DRUG,0.41050028800964355,DOSAGE-DRUG,0.4324460029602051,No relation,0.5215928554534912,No relation,0.5177690982818604,7,5,0,0
9838,[E2] ipratropium/-/albuterol [E2/] [E1] 18/-/103/mcg///Actuation [E1/] Aerosol Sig : Two ( 2 ) Puff Inhalation Q6H ( every 6 hours ) .,1,DOSAGE-DRUG,0.525266170501709,DOSAGE-DRUG,0.38683295249938965,DOSAGE-DRUG,0.38667917251586914,DOSAGE-DRUG,0.48720312118530273,5,5,5,5
6579,"# Transitional issues : - discontinue levofloxacin after [ ** 2169-3-10 ** ] ( 8/day course started [ ** 3 - 3 ** ] ) - goal O2 sat 88 - 92 % ( patient has been reaching this goal with 1.5 L NC ) - avoid nebulizers as high flow oxygen has worsened/respiratory distress , patient is stable on albuterol inhalers and tiotropium - patient was full code throughout admission ; several family meetings confirmed her wishes for cardiopulmonary resuscitation if necessary Medications on Admission : vitamin/d 50,000/units qmonth amlodipine 5/mg daily asa 81/mg daily mvi daily alprazolam 0.25/mg q6hr trazadone 25/mg qid/prn anxiety ventolin 90mcg q4hr advair 250/-/500mcg [ ** Hospital1 ** ] [E2] spiriva [E2/] 18mcg [E1] cap [E1/] daily CloniDINE 0.5/mg daily omeprazole 20/mg daily tums [ ** Hospital1 ** ] levaquin 500/mg daily - since [ ** 2 - 9 ** ] ( unclear why started ) colace polyethylene/glycol Discharge Medications : 1 .",4,No relation,0.33002424240112305,DURATION-DRUG,0.4906492233276367,No relation,0.52069091796875,DURATION-DRUG,0.7614731788635254,0,7,0,7
74579,Patient given lasix 20/mg IV x 1 and an alb neb. .,0,DOSAGE-DRUG,0.37407612800598145,DOSAGE-DRUG,0.43216490745544434,DOSAGE-DRUG,0.6074399948120117,DOSAGE-DRUG,0.5601422786712646,5,5,5,5
79672,Tylenol 325/mg Tablet Sig : 1/-/2 Tablets PO every/4/-/6/hours/as needed : Not to exceed 4g / day .,0,DOSAGE-DRUG,0.4040708541870117,DOSAGE-DRUG,0.524770975112915,DOSAGE-DRUG,0.4079101085662842,DOSAGE-DRUG,0.6314668655395508,5,5,5,5
76652,14 .,0,No relation,0.5232126712799072,No relation,0.5162479877471924,No relation,0.5274279117584229,No relation,1.5694892406463623,0,0,0,0
70120,"However , the entire right cervical ICA is slightly diminutive in caliber relative to the left , and slightly irregular suggesting a long segment of atherosclerosis .",0,No relation,0.5144660472869873,No relation,0.33430004119873047,No relation,0.41498398780822754,No relation,0.4991178512573242,0,0,0,0
89189,"[ ** Doctor Last Name 412 ** ] [ ** Last Name ( Prefixes ) 413 ** ] , M.D. [ ** MD Number ( 1 ) 414 ** ] Dictated By :[ ** Name8 ( MD ) 964 ** ] MEDQUIST36 D : [ ** 2106-7-13 ** ] 09:36 T : [ ** 2106-7-13 ** ] 10:06 JOB # : [ ** Job Number 36738 ** ]",0,No relation,0.31833982467651367,No relation,0.3350849151611328,No relation,0.3705012798309326,No relation,0.5038042068481445,0,0,0,0
74596,2 .,0,ADE-DRUG,0.3747258186340332,DOSAGE-DRUG,0.5111837387084961,No relation,0.35770511627197266,No relation,0.5143210887908936,8,5,0,0
22257,There is diffuse septal thickening which is unchanged .,0,No relation,0.6796741485595703,No relation,0.3736610412597656,No relation,0.41306614875793457,No relation,0.4241678714752197,0,0,0,0
3913,[E2] Lipitor [E2/] 40/mg Tablet Sig : One/(/1/) [E1] Tablet [E1/] PO once/a/day .,4,DOSAGE-DRUG,0.6468601226806641,DOSAGE-DRUG,0.5224511623382568,DOSAGE-DRUG,0.4112722873687744,DOSAGE-DRUG,0.4764430522918701,5,5,5,5
26446,4 .,0,DURATION-DRUG,0.3414621353149414,DOSAGE-DRUG,0.4153318405151367,DOSAGE-DRUG,0.4460780620574951,No relation,0.5173900127410889,7,5,5,0
1288,"F , Pulse : 89 , RR : 26 , BP : 120/68 , O2Sat : 99 .",0,No relation,0.5202682018280029,No relation,0.3550148010253906,No relation,0.33834004402160645,No relation,0.4823141098022461,0,0,0,0
75906,Past Medical History : 1 ) Aplastic anemia / Hypocellular myelodysplastic syndrome with trisomy 8 and 21 .,0,No relation,0.36571621894836426,No relation,0.571739912033081,No relation,0.4679238796234131,No relation,0.5288600921630859,0,0,0,0
2284,"We have made the following changes to your medications : - [E2] levofloxacin [E2/] 750/mg [E1] once/a [E1/] day - take one more dose of this on [ ** 2166-12-22 ** ] - Linezolid 600/mg twice/a/day - take one dose tonight on [ ** 2166-12-21 ** ] and two doses 12/hours/apart on [ ** 2166-12-22 ** ] - Metronidazole 500/mg - take one dose tonight and three doses tomorrow , 8/hours/apart - decrease iron to tablet a/day Followup Instructions : Department : [ ** Hospital3 249 ** ] With : Dr. [ ** First Name8 ( NamePattern2 ) ** ] [ ** Last Name ( NamePattern1 ) ** ] When : FRIDAY [ ** 2166-12-19 ** ] at 11:10 AM With : [ ** Company 191 ** ] POST [ ** Hospital 894 ** ] CLINIC [ ** Telephone / Fax ( 1 ) 250 ** ] Building : SC [ ** Hospital Ward Name 23 ** ] Clinical Ctr [ ** Location ( un ) 895 ** ] Campus : EAST Best Parking : [ ** Hospital Ward Name 23 ** ] Garage This appointment is with a hospital based physician as part of your transition from the hospital back to your primary care provider , [ ** Last Name ( NamePattern4 ) ** ] .",3,DOSAGE-DRUG,0.5113732814788818,DOSAGE-DRUG,0.4294610023498535,No relation,0.6654651165008545,DURATION-DRUG,1.0548679828643799,5,5,0,7
38000,If re-bleeds will need repeat EGD .,0,No relation,0.4581902027130127,No relation,0.34596681594848633,No relation,0.6991353034973145,No relation,0.520108699798584,0,0,0,0
944,4 .,0,DURATION-DRUG,0.3503868579864502,DOSAGE-DRUG,0.4094219207763672,DOSAGE-DRUG,0.3659539222717285,No relation,0.6277892589569092,7,5,5,0
47819,IMPRESSION : 1 .,0,No relation,0.5222289562225342,No relation,0.5236310958862305,No relation,0.5240240097045898,No relation,0.5221741199493408,0,0,0,0
8896,"HR 30 - 60s , BP 80s - 115s , temp to 33deg on bear hugger .",0,No relation,0.5216882228851318,No relation,0.36069416999816895,No relation,0.4893839359283447,No relation,0.5227360725402832,0,0,0,0
44830,"[E2] Aspirin [E2/] 81/mg Tablet/,/Chewable Sig : [E1] One [E1/] ( 1 ) Tablet/,/Chewable PO DAILY ( Daily ) .",5,DOSAGE-DRUG,0.3533611297607422,DOSAGE-DRUG,0.37467432022094727,DOSAGE-DRUG,0.3828160762786865,STRENGTH-DRUG,0.644489049911499,5,5,5,1
88536,Appeared euvolemic on exam .,0,No relation,0.5184371471405029,No relation,0.519399881362915,No relation,0.523695707321167,No relation,0.9059920310974121,0,0,0,0
1082,". # Depression / Anxiety : SHe has severe depression , uncontrolled .",0,REASON-DRUG,0.2943117618560791,No relation,0.4290182590484619,No relation,0.4050638675689697,No relation,0.4621400833129883,6,0,0,0
71688,A subset express CD20 .,0,No relation,0.45858097076416016,No relation,0.49871277809143066,No relation,0.5222909450531006,No relation,0.5170371532440186,0,0,0,0
59990,[E2] docusate/sodium [E2/] 100/mg Capsule Sig : One/(/1/) [E1] Capsule [E1/] PO BID/(/2 times a day ) .,4,DOSAGE-DRUG,0.39835596084594727,DOSAGE-DRUG,0.37444305419921875,DOSAGE-DRUG,0.459399938583374,DOSAGE-DRUG,0.5991439819335938,5,5,5,5
15510,"Family History : NC Physical Exam : 97.5 80 120/80 18 100 RA PE : Gen - NAD , anicteric , no jaundice , dobhoff in place , still appears malnourished but somewhat improved from prior exams CV - RRR Pulm - unlabored , CTA b / l Abd - soft , NT , ND .",0,No relation,0.270582914352417,No relation,0.3398559093475342,No relation,0.443850040435791,No relation,0.75636887550354,0,0,0,0
75484,. 6 .,0,No relation,0.3198730945587158,No relation,0.3878641128540039,No relation,0.35555386543273926,No relation,0.5817699432373047,0,0,0,0
58602,"He reports "" I do n't do well with IVs .",0,No relation,0.2897672653198242,No relation,0.32591891288757324,No relation,0.3573489189147949,No relation,0.5590879917144775,0,0,0,0
70569,He underwent pericardiocentesis with drain placement with drainage of bloody fluid .,0,No relation,0.4973790645599365,No relation,0.48213791847229004,No relation,0.3620266914367676,No relation,0.6778550148010254,0,0,0,0
57600,. Portable TTE ( Complete ) Done [ ** 2131-9-24 ** ] at 3:06:14 PM IMPRESSION : Moderate aortic valve stenosis .,0,No relation,0.29768896102905273,No relation,0.38440799713134766,No relation,0.43979883193969727,No relation,0.5969879627227783,0,0,0,0
46915,oxazepam 10/mg TID 3 .,0,DOSAGE-DRUG,0.45435380935668945,DOSAGE-DRUG,0.48125696182250977,DOSAGE-DRUG,0.46445488929748535,FREQUENCY-DRUG,0.5922996997833252,5,5,5,3
47827,"Otherwise , the lung bases are clear .",0,No relation,0.42850422859191895,No relation,0.35811781883239746,No relation,0.3281421661376953,No relation,0.4913809299468994,0,0,0,0
42014,[E2] Docusate [E2/] Sodium 100/mg [E1] Tablet [E1/] Sig : One/(/1/) Tablet PO twice/a day .,4,DOSAGE-DRUG,0.4670248031616211,DOSAGE-DRUG,0.5095119476318359,DOSAGE-DRUG,0.5149610042572021,DOSAGE-DRUG,0.5031158924102783,5,5,5,5
37205,All bronchial arteries and branches presented with very small caliber .,0,No relation,0.34504222869873047,No relation,0.6701869964599609,No relation,0.5177609920501709,No relation,0.5885770320892334,0,0,0,0
45862,The IVC is patent with usual directional flow .,0,No relation,0.32352590560913086,No relation,0.3474547863006592,No relation,0.35549306869506836,No relation,0.5678229331970215,0,0,0,0
9436,A central/line was placed and she was transfused a total of 9/units [E2] PRBCs [E2/] during her [E1] six/-/day [E1/] course in the unit .,7,DOSAGE-DRUG,0.41219305992126465,DOSAGE-DRUG,0.42722010612487793,DOSAGE-DRUG,0.5033233165740967,DOSAGE-DRUG,0.5070509910583496,5,5,5,5
26385,Relative prominence of the central pulmonary vessels is identified but more attenuated appearance of the periphery does not demonstrate any evidence of advanced CHF .,0,No relation,0.3482081890106201,No relation,0.3149869441986084,No relation,0.37843894958496094,No relation,0.9658722877502441,0,0,0,0
17913,[E2] nifedipine [E2/] [E1] 60/mg [E1/] Tablet/Extended/Rel/24/hr Sig : One/(/1/) Tablet/Extended/Rel/24/hr PO once/a/day .,1,DOSAGE-DRUG,0.2978849411010742,DOSAGE-DRUG,0.4179809093475342,FORM-DRUG,0.36165308952331543,STRENGTH-DRUG,0.47312283515930176,5,5,4,1
5757,[E2] Senna [E2/] 8.6/mg Tablet Sig : One/(/1/) Tablet [E1] PO [E1/] BID/(/2/times/a day ) as needed .,2,DOSAGE-DRUG,0.3789551258087158,DOSAGE-DRUG,0.37162208557128906,DOSAGE-DRUG,0.49038100242614746,DOSAGE-DRUG,0.5765647888183594,5,5,5,5
25776,"[E2] Amiodarone [E2/] 200/mg Tablet Sig : [E1] Two/(/2/) [E1/] Tablet PO BID/(/2/times a day ) for/5/days ; then 400/mg daily for/one/week , then 200/mg daily ongoing .",5,DOSAGE-DRUG,0.295015811920166,DOSAGE-DRUG,0.4681112766265869,DOSAGE-DRUG,0.3753969669342041,DOSAGE-DRUG,0.5547277927398682,5,5,5,5
75793,Final recommendations from the neurology service are for coumadin as soon as cleared by GI with 325/mg aspirin daily until then ; to follow - up with primary neurologist .,0,No relation,0.3318049907684326,DOSAGE-DRUG,0.4392662048339844,DOSAGE-DRUG,0.6083889007568359,DOSAGE-DRUG,0.5625720024108887,0,5,5,5
4221,* Your pain is not improving within 8 - 12 hours or not gone within 24 hours .,0,DURATION-DRUG,0.29834699630737305,DURATION-DRUG,0.43028783798217773,DURATION-DRUG,0.4456968307495117,No relation,0.4463191032409668,7,7,7,0
88065,". DISCHARGE LABS : [ ** 2173-11-17 ** ] 07:25 AM BLOOD WBC - 10.0 RBC - 2.87 * Hgb - 8.9 * Hct - 28.7 * MCV - 100 * MCH - 31.2 MCHC - 31.2 RDW - 17.6 * Plt Ct - 382 [ ** 2173-11-16 ** ] 06:36 AM BLOOD Neuts - 96.7 * Lymphs - 2.3 * Monos - 0.6 * Eos - 0.2 Baso - 0.1 [ ** 2173-11-17 ** ] 07:25 AM BLOOD PT - 12.2 PTT - 27.8 INR ( PT ) - 1.1 [ ** 2173-11-17 ** ] 07:25 AM BLOOD Glucose - 93 UreaN - 9 Creat - 0.2 * Na - 129 * K - 4.0 Cl - 92 * HCO3 - 31 AnGap - 10 [ ** 2173-11-17 ** ] 07:25 AM BLOOD Calcium - 8.5 Phos - 3.6 Mg - 1.5 * Brief Hospital Course : 61yo man with metastatic NSCLC to ribs , malignant effusion , and encasement of right hilum , on enoxaparin for PE , Pleurex catheter for malignant effusion , hx of CVA admitted to the ICU for acute dyspnea .",0,No relation,0.4206807613372803,No relation,0.3606100082397461,No relation,0.46796202659606934,No relation,0.7816932201385498,0,0,0,0
26374,"He specifically denies any problems with dysphagia , pain with eating or swallowing , choking , food getting stuck , early satiety , nausea or vomiting .",0,No relation,0.4613358974456787,No relation,0.522061824798584,No relation,0.5867609977722168,No relation,0.5279490947723389,0,0,0,0
24861,The MICU team was called .,0,No relation,0.29940128326416016,No relation,0.3913540840148926,No relation,0.3501160144805908,No relation,0.5633020401000977,0,0,0,0
4703,Motor : Normal bulk and tone bilaterally .,0,No relation,0.37676286697387695,No relation,0.33608293533325195,No relation,0.3163938522338867,No relation,0.43117785453796387,0,0,0,0
14408,. [E1] # [E1/] [E2] CHF [E2/] Lasix was initially held in setting of hypotension .,6,REASON-DRUG,0.553659200668335,ADE-DRUG,0.42975687980651855,REASON-DRUG,0.3670341968536377,REASON-DRUG,0.5124077796936035,6,8,6,6
42695,. # . BPH : No active issues .,0,No relation,0.2816319465637207,No relation,0.5334577560424805,No relation,0.3844728469848633,No relation,0.806481122970581,0,0,0,0
72102,Had thoracentesis in ED 1200cc straw colored fluid .,0,No relation,0.27158188819885254,No relation,0.4628479480743408,No relation,0.3970355987548828,No relation,0.43056201934814453,0,0,0,0
5182,3 .,0,DURATION-DRUG,0.3594377040863037,DOSAGE-DRUG,0.46626996994018555,DOSAGE-DRUG,0.4040210247039795,No relation,0.5145421028137207,7,5,5,0
77228,Vanco was continued .,0,No relation,0.3344550132751465,No relation,0.35268187522888184,No relation,0.33744192123413086,No relation,0.5132701396942139,0,0,0,0
42016,Bisacodyl 10/mg Suppository Sig : One/(/1/) Suppository Rectal HS/(/at/bedtime/)/as/needed : for constipation .,0,ROUTE-DRUG,0.3123738765716553,REASON-DRUG,0.3567690849304199,REASON-DRUG,0.41607117652893066,ROUTE-DRUG,0.46723413467407227,2,6,6,2
81662,albuterol/sulfate 90/mcg///actuation HFA/Aerosol/Inhaler Sig : Two/(/2/) Puff Inhalation Q6H/(/every/6/hours/)/as/needed for astma .,0,DOSAGE-DRUG,0.3653862476348877,DOSAGE-DRUG,0.4031369686126709,DOSAGE-DRUG,0.381817102432251,DOSAGE-DRUG,0.5072441101074219,5,5,5,5
79864,Lorazepam 0.5/mg Tablet Sig : One/(/1/) Tablet PO Q4/-/6H/(/every/4 to 6 hours ) as needed .,0,DOSAGE-DRUG,0.4122481346130371,DOSAGE-DRUG,0.5227172374725342,DOSAGE-DRUG,0.4253201484680176,FREQUENCY-DRUG,0.6789209842681885,5,5,5,3
46312,3 .,0,DURATION-DRUG,0.45815086364746094,DOSAGE-DRUG,0.42723703384399414,DOSAGE-DRUG,0.6699650287628174,No relation,0.49216794967651367,7,5,5,0
75010,7 .,0,No relation,0.3174912929534912,DOSAGE-DRUG,0.441770076751709,No relation,0.3467230796813965,No relation,0.46942687034606934,0,5,0,0
35355,[E2] cholecalciferol [E2/] ( vitamin D3 ) 400/unit Tablet [ ** Month / Year ( 2 ) ** ] : One/(/1/) [E1] Tablet [E1/] PO DAILY/(/Daily/) .,4,DOSAGE-DRUG,0.3239562511444092,DOSAGE-DRUG,0.38450098037719727,DOSAGE-DRUG,0.39296507835388184,DOSAGE-DRUG,0.6215121746063232,5,5,5,5
42734,[E2] fluconazole [E2/] 200/mg Tablet Sig : One/(/1/) Tablet [E1] PO [E1/] Q24H/(/every 24 hours ) .,2,DOSAGE-DRUG,0.5155167579650879,DOSAGE-DRUG,0.5139248371124268,FREQUENCY-DRUG,0.39815688133239746,FREQUENCY-DRUG,0.5050802230834961,5,5,3,3
67419,Fluticasone - Salmeterol 250/-/50/mcg///Dose Disk/with/Device Sig : One/(/1/) puff Inhalation twice/a day .,0,DOSAGE-DRUG,0.47161197662353516,DOSAGE-DRUG,0.5200061798095703,DOSAGE-DRUG,0.7122952938079834,DOSAGE-DRUG,0.5144069194793701,5,5,5,5
35799,He was given [E1] 40/mg [E1/] IV [E2] lasix [E2/] and put out ~ 1.5 L with some improvement in his oxygenation .,1,DOSAGE-DRUG,0.5337939262390137,DOSAGE-DRUG,0.5078909397125244,DOSAGE-DRUG,0.5232598781585693,DOSAGE-DRUG,0.4754753112792969,5,5,5,5
50278,Pre-op Labs : [ ** 2158-4-27 ** ] 09:40 PM PT - 11.8 PTT - 29.2 INR ( PT ) - 1.1 [ ** 2158-4-27 ** ] 09:40 PM PLT COUNT - 217 [ ** 2158-4-27 ** ] 09:40 PM WBC - 5.5 RBC - 3.73 * HGB - 11.3 * HCT - 34.1 * MCV - 91 MCH - 30.4 MCHC - 33.2 RDW - 13.1 [ ** 2158-4-27 ** ] 09:40 PM ALBUMIN - 4.3 CALCIUM - 9.1 PHOSPHATE - 3.0 MAGNESIUM - 2.2 [ ** 2158-4-27 ** ] 09:40 PM LIPASE - 47 % HbA1c - 5.6 eAG - 114 [ ** 2158-4-27 ** ] 09:40 PM ALT ( SGPT ) - 38 AST ( SGOT ) - 32 ALK PHOS - 24 * AMYLASE - 75 TOT BILI - 0.2 [ ** 2158-4-27 ** ] 09:40 PM GLUCOSE - 101 * UREA N - 24 * CREAT - 1.6 * SODIUM - 137 POTASSIUM - 4.3 CHLORIDE - 103 TOTAL CO2 - 25 ANION GAP - 13 Discharge labs : [ ** 2158-5-8 ** ] 03:45 AM BLOOD WBC - 5.7 RBC - 3.08 * Hgb - 9.3 * Hct - 28.2 * MCV - 92 MCH - 30.2 MCHC - 33.0 RDW - 13.6 Plt Ct - 237 [ ** 2158-5-8 ** ] 03:45 AM BLOOD Plt Ct - 237 [ ** 2158-5-8 ** ] 03:45 AM BLOOD Glucose - 109 * UreaN - 31 * Creat - 1.6 * Na - 134 K - 4.0 Cl - 96 HCO3 - 27 AnGap - 15 Brief Hospital Course : Mr. [ ** Known lastname 26644 ** ] was admitted to the [ ** Hospital1 18 ** ] on [ ** 2158-4-27 ** ] for surgical management of his coronary artery disease .,0,No relation,0.4342470169067383,No relation,0.5199081897735596,No relation,0.5557818412780762,No relation,0.7626900672912598,0,0,0,0
15524,He was treated [E1] for/a/total [E1/] of 12 days of dapto ( [ ** Date range ( 1 ) 81979 ** ] ) and [E2] meropenum [E2/] ( [ ** Date range ( 1 ) 81980 ** ] ) .,7,DURATION-DRUG,0.33704614639282227,DURATION-DRUG,0.4033527374267578,DURATION-DRUG,0.48075199127197266,DURATION-DRUG,0.5688357353210449,7,7,7,7
2004,"No other history provided by worker who was with patient in the ED , and the patient is not able to provide any additional history .",0,No relation,0.4938180446624756,No relation,0.4865720272064209,No relation,0.3187720775604248,No relation,0.48392510414123535,0,0,0,0
56499,Phone number [ ** Telephone / Fax ( 1 ) 128 ** ] .,0,No relation,0.267258882522583,No relation,0.5686142444610596,No relation,0.3500039577484131,No relation,0.6180429458618164,0,0,0,0
76618,". # Electrolytes : The patient required extensive repletion of his potassium during his ICU course , often requiring q6hr lyte checks and 100 - 200meq of K + per day .",0,ADE-DRUG,0.33539390563964844,DOSAGE-DRUG,0.38069891929626465,No relation,0.3381538391113281,No relation,0.5066502094268799,8,5,0,0
23938,"He did have a drug [E1] rash [E1/] earlier in his hospital course , thought to be related to micafungin or [E2] meropenem [E2/] , but it is unclear what caused the AIN .",8,ADE-DRUG,0.3072326183319092,ADE-DRUG,0.37126874923706055,ADE-DRUG,0.35645294189453125,ADE-DRUG,0.5211117267608643,8,8,8,8
43656,. MEDS on Transfer [E2] : [E2/] Protonix [E1] 40/mg [E1/] IV BID MVI po daily Thiamine 100/mg qday Folate i/mg po daily nicotine patch 14gm qday nadolol 20/mg qday oxazepam q2/prn for agitation per CIWA [ ** 6 - 18 ** ] 10 mg 13 - 20 20 mg Octreotide gtt Discharge Medications : 1 .,2,DOSAGE-DRUG,0.5205190181732178,No relation,0.5187509059906006,No relation,0.5255088806152344,DOSAGE-DRUG,0.5162708759307861,5,0,0,5
61031,Has on average a bottle of wine / week when he can afford it .,0,No relation,0.33872389793395996,No relation,0.328387975692749,No relation,0.5771660804748535,No relation,0.40645599365234375,0,0,0,0
67123,=============== OTHER STUDIES =============== ECG [ ** 2196-10-26 ** ] : Sinus bradycardia .,0,No relation,0.3041110038757324,No relation,0.3705122470855713,No relation,0.3355398178100586,No relation,0.5604190826416016,0,0,0,0
69057,"He was continued on : nystatin , miconazole , benadryl , sarna , Hydrocerin , HydrOXYzine , eye drops , Gelclair .",0,No relation,0.4189109802246094,No relation,0.3455049991607666,No relation,0.393604040145874,No relation,0.4103240966796875,0,0,0,0
83162,"For nausea/control , she was kept on compazine , zofran , ativan , phenergen PRN .",0,REASON-DRUG,0.8411369323730469,REASON-DRUG,0.42976880073547363,REASON-DRUG,0.47850894927978516,REASON-DRUG,0.5825726985931396,6,6,6,6
86882,His wife was in agreement that he should not receive any invasive procedures in the future .,0,No relation,0.3376808166503906,No relation,0.5086278915405273,No relation,0.36882495880126953,No relation,0.8551428318023682,0,0,0,0
78860,"Toward the end of his hospital stay , the patient did have increased diarrhea .",0,ADE-DRUG,0.3353421688079834,No relation,0.4386470317840576,ADE-DRUG,0.47089385986328125,No relation,0.5090751647949219,8,0,8,0
69599,3 .,0,DURATION-DRUG,0.3566429615020752,DOSAGE-DRUG,0.4595189094543457,DOSAGE-DRUG,0.5219020843505859,No relation,0.5233399868011475,7,5,5,0
64894,"In particular , it is important to continue the Serax and give Ativan p.r.n. for withdrawal/symptoms .",0,REASON-DRUG,0.5193328857421875,REASON-DRUG,0.5221970081329346,REASON-DRUG,0.5206620693206787,REASON-DRUG,0.53891921043396,6,6,6,6
7815,[E2] Januvia [E2/] * NF * ( sitaGLIPtin ) 25/mg [E1] Oral [E1/] daily 4 .,2,DOSAGE-DRUG,0.5067157745361328,DOSAGE-DRUG,0.358536958694458,DOSAGE-DRUG,0.5634112358093262,STRENGTH-DRUG,0.6479451656341553,5,5,5,1
70381,There may be partially occlusive thrombus in the left common iliac .,0,No relation,0.2888760566711426,No relation,0.34082603454589844,No relation,0.4167208671569824,No relation,0.5499892234802246,0,0,0,0
78418,Also initially held beta/blocker and ACE/inhibitor as PR prolongation and ARF .,0,REASON-DRUG,0.3065919876098633,REASON-DRUG,0.40137505531311035,REASON-DRUG,0.351560115814209,REASON-DRUG,0.5790383815765381,6,6,6,6
46754,Episodes of abdominal pain with negative bloodtests .,0,No relation,0.5111432075500488,No relation,0.4358792304992676,No relation,0.520054817199707,No relation,0.5195419788360596,0,0,0,0
37025,Medications on Admission : Home Meds : Amlodopine 5/mg daily atorvastatin 20/mg daily furosemide 40/mg [ ** Hospital1 ** ] glimepiride 4/mg daily humalog/insulin sliding/scale imdur 60/mg [ ** Hospital1 ** ] [E2] lidoderm [E2/] [E1] patch [E1/] [ ** Hospital1 ** ] nitroglycerin spray prn pentoxifylline SR 400/mg TID with meals diovan 320/mg daily aspirin 325/mg dialy calcium/+/D 600/200/units [ ** Hospital1 ** ] cyanocobalamin ( unknown dose ) multivitamin daily Omega/3/fatty/acids 1000/mg daily .,4,No relation,0.31260204315185547,No relation,0.3922600746154785,FORM-DRUG,0.5216982364654541,FORM-DRUG,0.565850019454956,0,0,4,4
74868,Patient was transferred to medicine service for workup of anemia and treatment of metabolic issues .,0,No relation,0.3852221965789795,No relation,0.42993974685668945,No relation,0.3279280662536621,No relation,0.43422603607177734,0,0,0,0
75013,Prevacid 15/milligrams po q/day .,0,DOSAGE-DRUG,0.3051011562347412,DOSAGE-DRUG,0.3790261745452881,DOSAGE-DRUG,0.4584040641784668,DOSAGE-DRUG,0.48814988136291504,5,5,5,5
33622,It was felt that your [E1] mental/status/changes [E1/] were likely related to an excess amount of [E2] pain/medications [E2/] as well as your underlying severe COPD .,8,ADE-DRUG,0.39501309394836426,ADE-DRUG,0.5220208168029785,REASON-DRUG,0.5201461315155029,REASON-DRUG,0.5253860950469971,8,8,6,6
46376,[E2] acetaminophen [E2/] 325/mg Tablet Sig : Two/(/2/) Tablet PO Q6H/(/every 6 hours ) as needed for [E1] fever [E1/] .,6,DOSAGE-DRUG,0.35886096954345703,REASON-DRUG,0.5009839534759521,REASON-DRUG,0.5185930728912354,REASON-DRUG,0.5354268550872803,5,6,6,6
64316,[E2] Warfarin [E2/] 2/mg Tablet Sig : One/(/1/) Tablet PO [E1] DAILY16/(/Once/Daily [E1/] at 16 ) .,3,DOSAGE-DRUG,0.3885228633880615,DOSAGE-DRUG,0.3719038963317871,DOSAGE-DRUG,0.3918001651763916,DOSAGE-DRUG,0.6174881458282471,5,5,5,5
15817,[ ** 2106-2-13 ** ] 3:20 PM CTA ABD W&W / O C & RECONS ; CT ABDOMEN W / CONTRAST [E1] CT [E1/] ABDOMEN WITHOUT AND WITH IV [E2] CONTRAST [E2/] : Hazy nodular opacities about the airways within the lower lungs have increased since the prior study consistent with small airways disease .,6,No relation,0.37125706672668457,FORM-DRUG,0.5433950424194336,No relation,0.42783689498901367,No relation,0.5083861351013184,0,4,0,0
62071,Medications on Admission : Captopril 25/mg [ ** Hospital1 ** ] Citalopram 60/mg daily Coreg 6.25/mg [ ** Hospital1 ** ] Digoxin 0.125/mg daily [E2] Folate [E2/] [E1] 4/mg [E1/] daily Trazodone 50/mg qHS Fosamax 70/mg qweek Lasix 40/mg daily Levothyroxine 75/mg daily Plavis 75/mg daily Zocor 20/mg daily Discharge Medications : 1 .,1,No relation,0.3425459861755371,No relation,0.38919973373413086,No relation,0.3261291980743408,DOSAGE-DRUG,0.6091177463531494,0,0,0,5
61143,[E2] Montelukast/Sodium [E2/] 10/mg PO [E1] DAILY [E1/] RX * Singulair 10/mg 1 Tablet/(/s/) by/mouth daily Disp # * 30 Tablet Refills : * 0 5 .,3,DOSAGE-DRUG,0.4374117851257324,DOSAGE-DRUG,0.3727271556854248,FREQUENCY-DRUG,0.36188697814941406,FREQUENCY-DRUG,0.4628920555114746,5,5,3,3
52732,The PICC line was pulled and she was admitted for anticoagulation .,0,REASON-DRUG,0.36753201484680176,REASON-DRUG,0.3728911876678467,No relation,0.33361005783081055,No relation,0.5401017665863037,6,6,0,0
38637,She had a run of atrial tachycardia 2 minutes into recovery lasting for 6 beats .,0,No relation,0.3329019546508789,No relation,0.4623899459838867,No relation,0.37897706031799316,No relation,0.4384331703186035,0,0,0,0
14093,Patient has had one week of increasing productive cough .,0,No relation,0.35639405250549316,No relation,0.3806169033050537,No relation,0.3687582015991211,No relation,0.4550189971923828,0,0,0,0
42013,[E2] Docusate [E2/] Sodium 100/mg Tablet Sig : [E1] One/(/1/) [E1/] Tablet PO twice/a day .,5,DOSAGE-DRUG,0.3025839328765869,DOSAGE-DRUG,0.4290637969970703,DOSAGE-DRUG,0.5684988498687744,DOSAGE-DRUG,0.5608067512512207,5,5,5,5
7741,Lungs sounded a lot clearer with residual right base crackles .,0,No relation,0.280181884765625,No relation,0.34950995445251465,No relation,0.39103269577026367,No relation,1.1508958339691162,0,0,0,0
90323,After he was extubated he was then transferred to the VICU for further recovery .,0,No relation,0.325634241104126,No relation,0.33875322341918945,No relation,0.39343810081481934,No relation,0.4395580291748047,0,0,0,0
16224,"HERPES SIMPLEX ( HSV ) 2 , IGG TEST RESULT REFERENCE RANGE ---- ------ --------------- Herpes II ( IgG ) Antibody 5.79 NEGATIVE HSV ( IgG ) Interpretation ANTIBODIES TO BOTH HSV TYPE 1 AND HSV TYPE 2 DETECTED .",0,No relation,0.3973679542541504,No relation,0.3802988529205322,No relation,0.6394829750061035,No relation,0.5151519775390625,0,0,0,0
56997,. You had acute/kidney/failure and were seen by the kidney specialists .,0,ADE-DRUG,0.3646268844604492,ADE-DRUG,0.43550896644592285,ADE-DRUG,0.40456223487854004,No relation,0.4845449924468994,8,8,8,0
53655,Moderate ( 2 + ) aortic regurgitation is seen .,0,No relation,0.3731107711791992,No relation,0.36080408096313477,No relation,0.41264915466308594,No relation,0.4748270511627197,0,0,0,0
29198,"Argatroban was administered intra-operatively Prolong intubation in SICU / requiring pressure support / metabolic acidosis On [ ** 5 - 2 ** ] , there was a period of [E1] hypotension [E1/] to 90s / 50s requiring [E2] pressor [E2/] support , but this was transient .",6,ADE-DRUG,0.31174302101135254,ADE-DRUG,0.5119717121124268,ADE-DRUG,0.41687488555908203,REASON-DRUG,0.44563889503479004,8,8,8,6
17118,The dose was uptitrated from 40/mg [E1] PO [E1/] [E2] lasix [E2/] to 80/mg PO lasix based on increased pulmonary/edema on CXR .,2,DOSAGE-DRUG,0.31806206703186035,DOSAGE-DRUG,0.4538838863372803,DOSAGE-DRUG,0.5631301403045654,DOSAGE-DRUG,0.5803821086883545,5,5,5,5
86425,"diltiazem HCl 120/mg Capsule , Extended Release Sig : One/(/1/) Capsule , Extended Release PO DAILY/(/Daily/) .",0,DOSAGE-DRUG,0.3979220390319824,DOSAGE-DRUG,0.46788907051086426,FREQUENCY-DRUG,0.5242781639099121,FORM-DRUG,0.527040958404541,5,5,3,4
23995,On transfer : Allopurinol 300/mg PO daily Ambien 5/mg PO QHS/prn insomnia Colace 100/mg PO BID Dulcolax 10/mg PO QAM/prn constipation Milk/of/Magnesia Q6h/prn constipation Mylanta 30/ml PO Q4h/prn Procardia/XL 30/mg PO daily Protonix 40/mg PO daily [E2] Reglan [E2/] [E1] 10/mg [E1/] IV Q6h/prn nausea Robitussin 10mL PO Q4h/prn cough Tylenol 650/mg PO Q6h/prn Zofran 4/mg IV Q8h/prn nausea Discharge Medications : 1 .,1,No relation,0.40973591804504395,No relation,0.5123052597045898,No relation,0.6314122676849365,FREQUENCY-DRUG,0.5345051288604736,0,0,0,3
14361,rare EtOH use .,0,No relation,0.2837052345275879,No relation,0.32183408737182617,No relation,0.42379283905029297,No relation,0.5094268321990967,0,0,0,0
66373,She was afebrile .,0,No relation,0.3380568027496338,No relation,0.36720895767211914,No relation,0.3458390235900879,No relation,0.5346579551696777,0,0,0,0
73742,4 .,0,DURATION-DRUG,0.3767569065093994,DOSAGE-DRUG,0.42337894439697266,DOSAGE-DRUG,0.38568663597106934,No relation,0.47007012367248535,7,5,5,0
36678,[E2] Acetaminophen [E2/] 325/-/650/mg PO Q6H/:/PRN [E1] pain [E1/] RX * acetaminophen 325/mg [ ** 11 - 22 ** ] tablet ( s ) by/mouth every/six/(/6/) hours Disp # * 120 Tablet Refills : * 0 13 .,6,DOSAGE-DRUG,0.39655494689941406,DOSAGE-DRUG,0.3592088222503662,REASON-DRUG,0.3689589500427246,DOSAGE-DRUG,0.8437559604644775,5,5,6,5
54147,Medications on Admission : Acyclovir 400/mg PO TID Bactrim DS 1 tab PO QD/3x///week [E2] Protonix [E2/] [E1] 40/mg [E1/] PO QD Folic/acid 1/mg PO QD Celexa 40/mg PO QD Discharge Medications : 1 .,1,No relation,0.27006101608276367,FORM-DRUG,0.3624587059020996,FORM-DRUG,0.4056260585784912,FREQUENCY-DRUG,0.5412027835845947,0,4,4,3
66712,# Acute on Chronic Hypercarbic repiratory failure : # Acute COPD exacerbation He presented to the ED with shortness of breath and change in mental status .,0,No relation,0.4968688488006592,No relation,0.4089019298553467,No relation,0.3341848850250244,No relation,0.48813605308532715,0,0,0,0
33755,". Plan going forward : Foley to be d / c 'd in 3 days , patient must void spontaneously 8 - 10 hours following the removal .",0,No relation,0.3315010070800781,No relation,0.3757791519165039,No relation,0.46592020988464355,No relation,0.47977495193481445,0,0,0,0
26762,[E2] Trimethoprim/-/Sulfamethoxazole [E2/] [E1] 80/-/400/mg [E1/] Tablet Sig : One/(/1/) Tablet PO DAILY/(/Daily/) .,1,DOSAGE-DRUG,0.2927091121673584,DOSAGE-DRUG,0.36072206497192383,DOSAGE-DRUG,0.4272770881652832,STRENGTH-DRUG,0.47225117683410645,5,5,5,1
75070,The patient had received temporary Foley catheter in the CCU and complained of mild urinary burning after its being taken out .,0,ADE-DRUG,0.31319689750671387,No relation,0.44294309616088867,No relation,0.316910982131958,No relation,0.4367978572845459,8,0,0,0
7854,You were given [E2] antibiotics [E2/] and for a [E1] few/days [E1/] we did n't give you any food by mouth and gave it instead through your IV .,7,ROUTE-DRUG,0.30718088150024414,DURATION-DRUG,0.35546302795410156,ROUTE-DRUG,0.36649513244628906,ROUTE-DRUG,0.5860528945922852,2,7,2,2
72240,levofloxacin 750/mg Tablet Sig : One/(/1/) Tablet PO DAILY ( Daily ) for/4/days .,0,DOSAGE-DRUG,0.3908679485321045,DOSAGE-DRUG,0.426624059677124,DOSAGE-DRUG,0.44301295280456543,DURATION-DRUG,0.5128200054168701,5,5,5,7
2280,"You did not have any [E1] seizures [E1/] during your hospitalizations , we continued all of your regular [E2] anti-/[/**/Known/lastname/862/**/]/medications [E2/] and monitored your levels , which were normal .",6,No relation,0.522590160369873,ADE-DRUG,0.5237419605255127,ADE-DRUG,0.33493614196777344,ADE-DRUG,0.4727659225463867,0,8,8,8
73609,The haptoglobin at [ ** Hospital1 18 ** ] was elevated pointing against hemolysis .,0,No relation,0.42283201217651367,No relation,0.5209221839904785,No relation,0.5207808017730713,No relation,0.5199360847473145,0,0,0,0
24814,Subcutaneous tissues were divided with the [ ** Last Name ( un ) 4161 ** ] and traction .,0,No relation,0.521608829498291,No relation,0.5227410793304443,No relation,0.521461009979248,No relation,0.5223398208618164,0,0,0,0
74359,SLEEP : The patient progressed from wakefulness to drowsiness but did not achieve stage II sleep .,0,No relation,0.5211818218231201,No relation,0.5209448337554932,No relation,0.5252397060394287,No relation,0.5116338729858398,0,0,0,0
84482,6 .,0,DURATION-DRUG,0.523367166519165,DOSAGE-DRUG,0.5232479572296143,No relation,0.3892531394958496,No relation,0.4624669551849365,7,5,0,0
30057,"CV : Regular rate and rhythm , normal S1 + S2 , no murmurs , rubs , gallops Abdomen : soft , non-tender , non-distended , bowel sounds present , no rebound tenderness or guarding , no organomegaly Ext : b / l edema left worse than right .",0,No relation,0.294755220413208,No relation,0.3426058292388916,No relation,0.4069368839263916,No relation,0.5129008293151855,0,0,0,0
43504,Followup Instructions : recommend outpatient Geriatrics consult with Dr. [ ** Last Name ( STitle ) 713 ** ] ( [ ** Telephone / Fax ( 1 ) 15260 ** ] .,0,No relation,0.26543211936950684,No relation,0.3165771961212158,No relation,0.3702540397644043,No relation,0.6107680797576904,0,0,0,0
88964,2 .,0,ADE-DRUG,0.31380200386047363,DOSAGE-DRUG,0.39638590812683105,No relation,0.4058239459991455,No relation,0.5048260688781738,8,5,0,0
33084,[E2] Amitriptyline [E2/] 50/mg PO [E1] HS [E1/] 3 .,3,DOSAGE-DRUG,0.47081494331359863,DOSAGE-DRUG,0.513063907623291,DOSAGE-DRUG,0.5210399627685547,ROUTE-DRUG,0.5212490558624268,5,5,5,2
36349,"Medications on Admission : MMF 1000/mg [ ** Hospital1 ** ] , protonix 40/mg daily , fluconazole 400/mg daily , valcyte 900/mg daily , [E2] plavix [E2/] [E1] 75/mg [E1/] daily , ASA 325/mg daily , Bactrim SS daily , metoprolol 25/mg tid , colace 100/mg [ ** Hospital1 ** ] , prednisone 17.5/mg daily , prograf 2/mg [ ** Hospital1 ** ] Discharge Medications : 1 .",1,No relation,0.3354990482330322,FORM-DRUG,0.3500192165374756,DOSAGE-DRUG,0.4860081672668457,DOSAGE-DRUG,0.49862098693847656,0,4,5,5
17171,[E2] Insulin/Regular/Human [E2/] 100/unit///mL [E1] Solution [E1/] Sig : One/(/1/) Injection ASDIR/(/AS/DIRECTED/) .,4,DOSAGE-DRUG,0.41159510612487793,DOSAGE-DRUG,0.5229520797729492,DOSAGE-DRUG,0.541071891784668,DOSAGE-DRUG,0.504072904586792,5,5,5,5
90351,Metformin 850/mg Tablet Sig : Two/(/2/) Tablet PO twice/a day .,0,DOSAGE-DRUG,0.32689714431762695,DOSAGE-DRUG,0.7271699905395508,DOSAGE-DRUG,1.0331740379333496,DOSAGE-DRUG,0.5488591194152832,5,5,5,5
24687,"You should continue your other outpatient medications as you did previously Followup Instructions : Name : [ ** Last Name ( LF ) ** ] , [ ** First Name3 ( LF ) ** ] V. MD Address : [ ** Location ( un ) 3881 ** ] , [ ** Apartment Address ( 1 ) 3882 ** ] , [ ** Location ( un ) ** ] , [ ** Numeric Identifier 3883 ** ] Phone : [ ** Telephone / Fax ( 1 ) 2349 ** ] Appointment : Friday [ ** 2130-10-6 ** ] 1:30 pm Name : [ ** Last Name ( LF ) 1447 ** ] , [ ** First Name7 ( NamePattern1 ) 1569 ** ] [ ** Initial ( NamePattern1 ) ** ] [ ** Last Name ( NamePattern4 ) ** ] Location : [ ** Location ( un ) ** ] FAMILY PRACTICE Address : [ ** Street Address ( 2 ) 75551 ** ] [ ** Apartment Address ( 1 ) 87446 ** ] , [ ** Location ( un ) ** ] , [ ** Numeric Identifier 75553 ** ] Phone : [ ** Telephone / Fax ( 1 ) 44915 ** ] Appointment : Wednesday [ ** 2130-10-11 ** ] 2:00 pm",0,No relation,0.36542701721191406,No relation,0.41478610038757324,No relation,0.45354795455932617,No relation,0.8182468414306641,0,0,0,0
22041,7 .,0,No relation,0.39104199409484863,DOSAGE-DRUG,0.6510951519012451,No relation,0.4155449867248535,No relation,0.6271889209747314,0,5,0,0
67961,Would consider starting low dose ACEi as outpatient .,0,REASON-DRUG,0.39152002334594727,ADE-DRUG,0.40833425521850586,No relation,0.41196274757385254,No relation,0.4746971130371094,6,8,0,0
3622,Height : ( in ) 68 Weight ( lb ) : 300 BSA ( m2 ) : 2.43 m2 BP ( mm Hg ) : 74/60 HR ( bpm ) : 66 Status : Inpatient Date / Time : [ ** 2195-12-25 ** ] at 10:55 Test : Portable TTE ( Complete ) Doppler : Full doppler and color doppler Contrast : None Tape Number : 2004W487 - 1:24 Test Location : West MICU Technical Quality : Suboptimal REFERRING DOCTOR : DR. [ ** First Name11 ( Name Pattern1 ) ** ] [ ** Initial ( NamePattern1 ) ** ] [ ** Last Name ( NamePattern4 ) ** ] MEASUREMENTS : Left Atrium - Long Axis Dimension : * 4.8 cm ( nl < = 4.0 cm ) Left Atrium - Four Chamber Length : * 5.8 cm ( nl < = 5.2 cm ) Right Atrium - Four Chamber Length : 5.0 cm ( nl < = 5.0 cm ) Left Ventricle - Septal Wall Thickness : * 1.2 cm ( nl 0.6 - 1.1 cm ) Left Ventricle - Inferolateral Thickness : 0.9 cm ( nl 0.6 - 1.1 cm ) Left Ventricle - Diastolic Dimension : * 5.7 cm ( nl < = 5.6 cm ) Left Ventricle - Ejection Fraction : * < = 25 % ( nl > = 55 % ) Aorta - Valve Level : 3.6 cm ( nl < = 3.6 cm ) Aorta - Ascending : * 3.5 cm ( nl < = 3.4 cm ) Aortic Valve - Peak Velocity : 1.0 m / sec ( nl < = 2.0 m / sec ) Mitral Valve - E Wave : 0.7 m / sec Mitral Valve - E Wave Deceleration Time : 148 msec TR Gradient ( + RA = PASP ) : * 25 to 30 mm Hg ( nl < = 25 mm Hg ) INTERPRETATION : Findings : LEFT ATRIUM : Mild LA enlargement .,0,No relation,0.3987100124359131,No relation,0.5241620540618896,No relation,0.5164668560028076,No relation,0.7676138877868652,0,0,0,0
75998,Primaquine and clindamycin were begun instead .,0,No relation,0.30692005157470703,ADE-DRUG,0.37134289741516113,No relation,0.35193800926208496,No relation,0.43868517875671387,0,8,0,0
44081,2 .,0,ADE-DRUG,0.8966877460479736,DOSAGE-DRUG,0.5236890316009521,No relation,0.51792311668396,No relation,0.5204291343688965,8,5,0,0
80613,"- To rehab facility : Please make sure to f / u vanc troughs every three days , as pt has unstable vancomycin pharmacokinetics ## Guiac/positive/stool : Pt with guiac positive melena .",0,ADE-DRUG,0.33731579780578613,ADE-DRUG,0.4711477756500244,No relation,0.4210360050201416,No relation,0.49988770484924316,8,8,0,0
11522,Moderate to severe tricuspid regurgitation .,0,No relation,0.3513309955596924,No relation,0.521899938583374,No relation,0.3345909118652344,No relation,0.47330689430236816,0,0,0,0
78021,Trivial mitral regurgitation is seen .,0,No relation,0.32243824005126953,No relation,0.5088059902191162,No relation,0.31913304328918457,No relation,0.46386194229125977,0,0,0,0
41063,The patient also developed an urticarial/rash on [ ** 2196-2-2 ** ] and this was attributed to having switched his [E2] Cipro [E2/] from [E1] IV [E1/] to PO .,2,ADE-DRUG,0.29860901832580566,ROUTE-DRUG,0.4012479782104492,ROUTE-DRUG,0.36977505683898926,ROUTE-DRUG,0.47539401054382324,8,2,2,2
34982,He received a [E1] 200cc [E1/] [E2] NS [E2/] IVF bolus with improvement to the 90s .,5,No relation,0.33756113052368164,FORM-DRUG,0.38422608375549316,FORM-DRUG,0.4045891761779785,DOSAGE-DRUG,0.528156042098999,0,4,4,5
15004,"[E2] tiotropium/bromide [E2/] [E1] 18/mcg [E1/] Capsule/,/w///Inhalation/Device Sig : One/(/1/) Cap Inhalation DAILY/(/Daily/) .",1,DOSAGE-DRUG,0.3782987594604492,DOSAGE-DRUG,0.39226317405700684,DOSAGE-DRUG,0.38327908515930176,DOSAGE-DRUG,0.509955883026123,5,5,5,5
84627,"She remained hemodynamically stable , afebrile , with UOP of 60 cc / hr overnight .",0,No relation,0.3498108386993408,No relation,0.351837158203125,No relation,0.3882579803466797,No relation,0.46985387802124023,0,0,0,0
87772,Per movement disorder specialists her exam has shown severe dystonia with some atypical features that raise a question of a psychogenic component as well .,0,No relation,0.33852529525756836,No relation,0.43500614166259766,No relation,0.39551210403442383,No relation,0.5042409896850586,0,0,0,0
25289,Hypotensive episode Secondary Diagnosis : - high - degree AV nodal disease s / p permanent pacemaker - severe Aortic Stenosis ( valve area 0.8 ) - hypertension - hyperlipidemia .,0,No relation,0.2867279052734375,No relation,0.3440678119659424,No relation,0.396651029586792,No relation,0.4563572406768799,0,0,0,0
79022,"He underwent CTA , and was found to have multifocal retroperitoneal bleed in the right kidney .",0,No relation,0.30550503730773926,No relation,0.4942619800567627,No relation,0.41229701042175293,No relation,0.5191822052001953,0,0,0,0
26315,He was treated with a 10mg///hr [E2] Dilt [E2/] [E1] drip [E1/] and spontaneously converted to sinus and he remained in sinus rhythm throughout the rest of his hospitalization .,2,ROUTE-DRUG,0.32047510147094727,DOSAGE-DRUG,0.5190839767456055,DOSAGE-DRUG,0.5195419788360596,DOSAGE-DRUG,0.5929720401763916,2,5,5,5
14999,"[E2] Saline [E2/] Nasal 0.65 % Aerosol/,/Spray Sig : [E1] One/(/1/) [E1/] spray Nasal twice/a/day .",5,ROUTE-DRUG,0.4468989372253418,ROUTE-DRUG,0.5222108364105225,DOSAGE-DRUG,0.521719217300415,DOSAGE-DRUG,0.5226688385009766,2,2,5,5
44792,[E2] Metoprolol/Tartrate [E2/] 25/mg Tablet Sig : One ( 1 ) Tablet PO [E1] BID [E1/] ( 2 times a day ) .,3,DOSAGE-DRUG,0.7564678192138672,DOSAGE-DRUG,0.45804715156555176,DOSAGE-DRUG,0.5235898494720459,FREQUENCY-DRUG,0.5875570774078369,5,5,5,3
42354,"Admission Date : [ ** 2133-9-17 ** ] Discharge Date : [ ** 2133-9-22 ** ] Date of Birth : [ ** 2084-5-25 ** ] Sex : F Service : SURGERY Allergies : Penicillins / Codeine Attending :[ ** Doctor First Name 5188 ** ] Chief Complaint : Abdominal pain , vomiting Major Surgical or Invasive Procedure : Right Chest tube placement at bedside History of Present Illness : 49 year old female with history of cervical cancer status post multiple ( ?",0,No relation,0.340670108795166,No relation,0.8438069820404053,No relation,0.41412782669067383,No relation,0.4691448211669922,0,0,0,0
63638,OUTPATIENT ISSUES : -- Close hemodynamic monitoring ; plan to re-initiate anti-hypertensives if needed .,0,No relation,0.47917795181274414,No relation,0.3467121124267578,No relation,0.39911699295043945,No relation,0.44087886810302734,0,0,0,0
66874,No cerebellar dysfunction .,0,No relation,0.36623597145080566,No relation,0.5217750072479248,No relation,0.5239801406860352,No relation,0.5509750843048096,0,0,0,0
83898,Intubation was not required .,0,No relation,0.3099491596221924,No relation,0.36577892303466797,No relation,0.37226390838623047,No relation,0.5598561763763428,0,0,0,0
87554,Take your blood sugar as directed by your primary doctor .,0,No relation,0.43727946281433105,No relation,0.518608808517456,No relation,0.561082124710083,No relation,0.4823720455169678,0,0,0,0
8306,6 .,0,DURATION-DRUG,0.3851656913757324,DOSAGE-DRUG,0.41495203971862793,No relation,0.39864444732666016,No relation,0.48384594917297363,7,5,0,0
79355,Patient given sucralfate .,0,DRUG-DRUG,0.45885205268859863,No relation,0.5475828647613525,No relation,0.4235999584197998,No relation,0.5376040935516357,0,0,0,0
21838,"On [ ** 2207-9-1 ** ] , we decreased you [E2] oxycontin [E2/] to 20/mg in/the/AM and [E1] 10/mg [E1/] at/night .",1,DOSAGE-DRUG,0.49994707107543945,DOSAGE-DRUG,0.5227231979370117,DOSAGE-DRUG,0.36084604263305664,DOSAGE-DRUG,0.7845859527587891,5,5,5,5
13263,Fluconazole Susceptibility testing requested by DR. [ ** Last Name ( STitle ) ** ] [ ** Name ( STitle ) ** ] # [ ** Numeric Identifier 11536 ** ] [ ** 2113-4-7 ** ] .,0,No relation,0.4146111011505127,No relation,0.5367317199707031,No relation,0.4977591037750244,No relation,0.566673755645752,0,0,0,0
75993,She was subsequently begun on Bactrim and steroids .,0,REASON-DRUG,0.4784080982208252,No relation,0.4061160087585449,ADE-DRUG,0.39931273460388184,No relation,0.4443230628967285,6,0,8,0
51581,"The patient was , therefore , started on a [E2] heparin [E2/] [E1] drip [E1/] to be titrated to a goal PTT between 40 to 60 seconds .",2,ROUTE-DRUG,0.3421027660369873,FORM-DRUG,0.47561216354370117,DOSAGE-DRUG,0.6088440418243408,ROUTE-DRUG,0.4443190097808838,2,4,5,2
22293,"On admission , toxicology screen revealed opiates and tricyclics , and by medical notes on transfer , patient had been using more sedating/medications than normal .",0,ADE-DRUG,0.32080984115600586,ADE-DRUG,0.3625788688659668,No relation,0.36594200134277344,No relation,0.5124630928039551,8,8,0,0
72666,Strength full power [ ** 5 - 20 ** ] in the uppers and [ ** 4 - 20 ** ] in the lowers .,0,STRENGTH-DRUG,0.2909409999847412,STRENGTH-DRUG,0.38129425048828125,No relation,0.3465569019317627,No relation,0.5147602558135986,1,1,0,0
9122,Moderate [ 2 + ] tricuspid regurgitation is seen .,0,No relation,0.5212130546569824,No relation,0.518693208694458,No relation,0.5240070819854736,No relation,0.5194852352142334,0,0,0,0
48251,[E2] Therapeutic/Multivitamin [E2/] [E1] Liquid [E1/] Sig : Five/(/5/)/ML PO DAILY/(/Daily/) .,4,DOSAGE-DRUG,0.5233559608459473,DOSAGE-DRUG,0.527533769607544,FORM-DRUG,0.5122780799865723,FORM-DRUG,0.5190188884735107,5,5,4,4
49494,"She began to feel ill one week ago when she acutely felt "" awful "" with low/-/grade/fevers , back/pain and thought she had the flu .",0,No relation,0.727747917175293,No relation,0.34041905403137207,No relation,1.2263329029083252,No relation,0.49545884132385254,0,0,0,0
73702,"He underwent an ERCP on [ ** 10 - 31 ** ] which did not show biliary tract obstruction , however , a CBD stent was placed .",0,No relation,0.3578920364379883,No relation,0.5222818851470947,No relation,0.523082971572876,No relation,0.552278995513916,0,0,0,0
19631,Assess for head [ ** Doctor Last Name ** ] .,0,No relation,0.49103283882141113,No relation,0.5234920978546143,No relation,0.35355591773986816,No relation,0.6896789073944092,0,0,0,0
73788,". On [ ** 11 - 9 ** ] , pt was noted to have EBSL/klebsiella in a sputum and BAL sample , and was begun on meropenem for/14/day course .",0,DURATION-DRUG,0.3483469486236572,DURATION-DRUG,0.34977197647094727,DURATION-DRUG,0.4089369773864746,DURATION-DRUG,0.537276029586792,7,7,7,7
56799,"Pathology showed ... Per GI consult recomendation , erythmocyin was stopped as [E1] PO [E1/] [E2] erythromycin [E2/] has no effect on gastroparesis and as IV erythromycin has limited effect due to tachyphylaxis .",2,ROUTE-DRUG,0.44445013999938965,ROUTE-DRUG,0.5189719200134277,REASON-DRUG,0.5238230228424072,REASON-DRUG,0.5259718894958496,2,2,6,6
76228,"CTAB , no crackles , wheezes or rhonchi .",0,No relation,0.5178413391113281,No relation,0.3325018882751465,No relation,0.32068419456481934,No relation,0.43669819831848145,0,0,0,0
20189,[E2] Folic/Acid [E2/] 1/mg Tablet Sig : One/(/1/) [E1] Tablet [E1/] PO DAILY/(/Daily/) .,4,DOSAGE-DRUG,0.47637104988098145,DOSAGE-DRUG,0.5209548473358154,DOSAGE-DRUG,0.5242781639099121,DOSAGE-DRUG,0.6670448780059814,5,5,5,5
89802,Recommend further evaluation with chest CT. .,0,No relation,0.3727388381958008,No relation,0.5229709148406982,No relation,0.5319149494171143,No relation,0.5236010551452637,0,0,0,0
35593,Medications on Admission : - Nitroglycerin 0.4/mg SL prn chest/pain - [E2] Lisinopril [E2/] 20/mg [E1] daily [E1/] - Sertraline 100/mg daily - Pantropazole 40/mg daily - Coumadin 5/mg daily - ASA 81/mg daily - Carvedilol 25/mg [ ** Hospital1 ** ] Discharge Medications : 1 .,3,No relation,0.33345770835876465,FORM-DRUG,0.35120177268981934,DOSAGE-DRUG,0.37192487716674805,DOSAGE-DRUG,0.5214509963989258,0,4,5,5
58175,[E2] Metoprolol [E2/] Tartrate 25/mg Tablet Sig : [E1] Three/(/3/) [E1/] Tablet PO BID/(/2/times/a/day/) .,5,DOSAGE-DRUG,0.4043130874633789,DOSAGE-DRUG,0.6196081638336182,DOSAGE-DRUG,0.5684611797332764,DOSAGE-DRUG,0.5303690433502197,5,5,5,5
15327,"[E2] Heparin [E2/] ( Porcine ) 5,000/unit / mL Solution Sig : One/(/1/) [E1] Injection [E1/] TID/(/3/times/a/day/) .",4,DOSAGE-DRUG,0.4649977684020996,DOSAGE-DRUG,0.5216677188873291,DOSAGE-DRUG,0.5237531661987305,DOSAGE-DRUG,0.5199849605560303,5,5,5,5
3265,[E2] Fluoxetine [E2/] 30/mg [E1] daily [E1/] 2 .,3,DOSAGE-DRUG,0.5358121395111084,DOSAGE-DRUG,0.5111348628997803,DOSAGE-DRUG,0.522392988204956,DOSAGE-DRUG,0.5268211364746094,5,5,5,5
52943,. # osteoarthritis : cont plaquenil Medications on Admission : diltiazem/CD 180/mg qday atarax 25 QID Vivelle dot 0.05 twice/per/week ranitidine 300/mg daily cymbalta 60/mg qday plaquenil 200 [ ** Hospital1 ** ] adderal/XR 25 fexofenadine 180 [ ** Hospital1 ** ] ambien 10 prn zofran 8 [E2] prn [E2/] [E1] dilaudid [E1/] 2 prn percocet prn fiorcet prn epi pen prn Discharge Medications : 1 .,3,No relation,0.2762150764465332,No relation,0.3459961414337158,No relation,0.4765920639038086,No relation,0.4630141258239746,0,0,0,0
10144,"The left ventricular inflow pattern suggests a restrictive filling abnormality , with elevated left atrial pressure .",0,No relation,0.29363417625427246,No relation,0.33704400062561035,No relation,0.49558496475219727,No relation,0.5062062740325928,0,0,0,0
15675,Family History : The family history is significant for a brain tumor in his mother .,0,No relation,0.5233619213104248,No relation,0.613563060760498,No relation,0.3695950508117676,No relation,0.5224440097808838,0,0,0,0
32487,"Medications on Admission : CLONIDINE - 0.1/mg Tablet - 1 tablet twice/a/day FLUTICASONE/[/FLONASE ] - 50/mcg Spray/,/Suspension - 1 spray inhaled apply to each/nostril twice/daily FOLIC/ACID - 1/mg Tablet - 1 Tablet/(/s/) by/mouth once/a/day FUROSEMIDE/[/LASIX ] - 40/mg Tablet - 1 Tablet/(/s/) by/mouth once a day LACTULOSE - 10/gram///15/mL Solutio - 30mls four/times/a/day LIDOCAINE - 5/%/(/700/mg///patch/) Adhesive/Patch/,/Medicated - 1 patch daily/wear/12/hours/on/then/take/off MIRTAZAPINE - 15/mg Tablet - 1 Tablet/(/s/) by/mouth at/bedtime NADOLOL - 40/mg Tablet - 1 Tablet/(/s/) by/mouth daily NICOTINE - 14/mg///24/hour Patch/24/hr - 1 patch daily PANTOPRAZOLE - 40/mg Tablet/,/Delayed/Release/(/E.C./) - 1 tablet PO twice/a/day SPIRONOLACTONE [ ALDACTONE ] - 100/mg Tablet - 1.5 Tablet/(/s/) by mouth once/a/day Medications - OTC FERROUS/SULFATE - 325/mg ( 65/mg ) Tablet - 1 Tablet/(/s/) by/mouth daily [E2] HEXAVITAMIN [E2/] - Tablet - [E1] 1 [E1/] tablet daily THIAMINE/HCL - 100/mg Tablet - 1/(/One/) Tablet/(/s/) by/mouth once a day Discharge Medications : 1 .",5,No relation,0.5264618396759033,No relation,0.5160958766937256,No relation,0.5487158298492432,FORM-DRUG,0.7191307544708252,0,0,0,4
5932,He attempted to walk to the bathroom but still suffered from severe vertigo and fell .,0,No relation,0.3420250415802002,No relation,0.4667320251464844,No relation,0.5185143947601318,No relation,0.5152239799499512,0,0,0,0
9346,We added : lisinopril 20/mg daily torsemide 20/mg twice/a day [E2] hydrocortisone [E2/] 2.5/% [E1] rectal [E1/] cream 1 application per/rectum daily with rectal/pain spironolactone 25/mg daily amlodipine 10/mg daily ferrous/sulphate 325/mg daily erythropoeitin/Alfa 4000/unit SC injection MWF atovaquone suspension 1500/mg daily while on prednisone nyastatin 5/ml p.o [ ** Hospital1 ** ] as/needed for oral/thrush .,2,DOSAGE-DRUG,0.5173959732055664,DOSAGE-DRUG,0.42580580711364746,ADE-DRUG,0.7135989665985107,FORM-DRUG,0.5194437503814697,5,5,8,4
29331,[E2] Warfarin [E2/] 3/mg Tablet [ ** Last Name ( STitle ) ** ] : One/(/1/) Tablet PO [E1] HS [E1/] ( at bedtime ) : goal [ ** 2 - 9 ** ] / INR .,3,DOSAGE-DRUG,0.40604305267333984,DOSAGE-DRUG,0.3550589084625244,DOSAGE-DRUG,0.4060990810394287,DOSAGE-DRUG,0.4905202388763428,5,5,5,5
56302,[E2] Metoclopramide [E2/] 10/mg Tablet Sig : One/(/1/) Tablet [E1] PO [E1/] QIDACHS ( 4 times a day ( before meals and at bedtime ) ) .,2,DOSAGE-DRUG,0.39289116859436035,ROUTE-DRUG,0.47953104972839355,FREQUENCY-DRUG,0.4515838623046875,FREQUENCY-DRUG,0.5144939422607422,5,2,3,3
70270,. ARF : Likely pre-renal .,0,REASON-DRUG,0.32170987129211426,No relation,0.34046077728271484,No relation,0.36937713623046875,No relation,0.5274522304534912,6,0,0,0
11729,"[E2] Clonidine [E2/] 0.1/mg Tablet Sig : [E1] One/(/1/) [E1/] Tablet PO taper/as directed as needed for nausea , vomiting , diahrrea , craving : Take one dose tonight ( [ ** 8 - 16 ** ] ) for a total of three times a day .",5,DOSAGE-DRUG,0.5156519412994385,DOSAGE-DRUG,0.5104660987854004,REASON-DRUG,0.5186820030212402,DOSAGE-DRUG,0.5251061916351318,5,5,6,5
20989,"[E2] Prednisone [E2/] 10/mg Tablet Sig : Six/(/6/) Tablet PO once/a day : for/2/days ( [ ** Date range ( 1 ) 25243 ** ] ) , then 5 [E1] tabs [E1/] daily for/2/days ( [ ** Date range ( 1 ) 25244 ** ] ) , then 4 tabs daily for/2/days ( 4/26/05 - 4/27 ) , then 3 tabs daily for/2/days ( [ ** 6 - 5 ** ] / - [ ** 6 - 6 ** ] ) , then 2 ts daily for/2/days ( [ ** Date range ( 1 ) 25245 ** ] ) , then 1 tab daily for/2/days ( [ ** Date range ( 1 ) 25246 ** ] ) .",4,DOSAGE-DRUG,0.5073728561401367,DOSAGE-DRUG,0.5171709060668945,DOSAGE-DRUG,0.5208063125610352,DOSAGE-DRUG,0.5133492946624756,5,5,5,5
4716,The mass elevates the third ventricle and causes compression at the level of the foramen of [ ** Last Name ( un ) 2044 ** ] .,0,No relation,0.38448405265808105,No relation,0.4425160884857178,No relation,0.41100382804870605,No relation,0.4898388385772705,0,0,0,0
67678,15 .,0,No relation,0.3647167682647705,No relation,0.3850681781768799,No relation,0.4095458984375,No relation,0.5195908546447754,0,0,0,0
80713,". [ ** 2146-3-10 ** ] CTA CHEST W&W / O C&RECONS , ABD / PELVIC CT W / CONTRAST : 1 .",0,No relation,0.3214550018310547,No relation,0.4146897792816162,No relation,1.0936620235443115,No relation,0.5058801174163818,0,0,0,0
6561,[E2] Albuterol [E2/] inhaler [E1] as/needed [E1/] and daily tioptrium restarted per home regimen .,3,ROUTE-DRUG,0.469404935836792,ROUTE-DRUG,0.5200667381286621,ROUTE-DRUG,0.5145609378814697,ROUTE-DRUG,0.5281360149383545,2,2,2,2
75193,. CXR : Comparison is made with prior study [ ** 2182-5-10 ** ] .,0,No relation,0.33590102195739746,No relation,0.36629581451416016,No relation,0.3353149890899658,No relation,0.6087260246276855,0,0,0,0
88383,There is moderate symmetric left ventricular hypertrophy .,0,No relation,0.42761802673339844,No relation,0.5167179107666016,No relation,0.38638997077941895,No relation,0.44634008407592773,0,0,0,0
65138,"Admission Date : [ ** 2125-9-3 ** ] Discharge Date : [ ** 2125-9-4 ** ] Date of Birth : [ ** 2078-2-8 ** ] Sex : M Service : MEDICINE Allergies : Iodine Containing Agents Classifier Attending :[ ** First Name3 ( LF ) 2186 ** ] Chief Complaint : flushing , periorbital edema , and hives during CT scan Major Surgical or Invasive Procedure : 1 .",0,No relation,0.3539299964904785,No relation,0.36254000663757324,No relation,0.3907961845397949,No relation,0.7230191230773926,0,0,0,0
54157,[E2] Acyclovir [E2/] 200/mg Capsule Sig : [E1] Two/(/2/) [E1/] Capsule PO Q8H/(/every/8 hours ) .,5,DOSAGE-DRUG,0.3361828327178955,DOSAGE-DRUG,0.4284188747406006,DOSAGE-DRUG,0.3883845806121826,FREQUENCY-DRUG,0.5246448516845703,5,5,5,3
83507,And treatment for possible pneumonia was continued .,0,REASON-DRUG,0.48003602027893066,REASON-DRUG,0.443925142288208,REASON-DRUG,0.47995996475219727,No relation,0.5045137405395508,6,6,6,0
56136,Discharge Instructions : No new medications were prescribed .,0,No relation,0.2940540313720703,No relation,0.39369916915893555,No relation,0.3987419605255127,No relation,0.7439589500427246,0,0,0,0
77730,You may need to restart some of these medications .,0,No relation,0.7827403545379639,No relation,0.5249588489532471,No relation,0.520582914352417,No relation,0.5233049392700195,0,0,0,0
37031,Medications on Admission : Home Meds : Amlodopine 5/mg daily atorvastatin 20/mg daily furosemide 40/mg [ ** Hospital1 ** ] glimepiride 4/mg daily humalog/insulin sliding/scale imdur 60/mg [ ** Hospital1 ** ] lidoderm patch [ ** Hospital1 ** ] nitroglycerin spray prn pentoxifylline SR 400/mg TID with meals [E2] diovan [E2/] [E1] 320/mg [E1/] daily aspirin 325/mg dialy calcium/+/D 600/200/units [ ** Hospital1 ** ] cyanocobalamin ( unknown dose ) multivitamin daily Omega/3/fatty/acids 1000/mg daily .,1,No relation,0.3440110683441162,No relation,0.3242506980895996,FORM-DRUG,0.5633490085601807,STRENGTH-DRUG,0.5284450054168701,0,0,4,1
41069,"He remained on the Vancomycin and [E2] Levofloxacin [E2/] for the/pneumonia [E1] for/a/total/of/7/day/course [E1/] , stop date [ ** 2196-2-10 ** ] .",7,DURATION-DRUG,0.3316960334777832,DURATION-DRUG,0.35614514350891113,DURATION-DRUG,0.3630068302154541,DURATION-DRUG,0.5061790943145752,7,7,7,7
